- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
From Guidelines to Practice: Advancing Lupus Nephritis Treatment
Amit Saxena, MD, discusses how evidence-based guidelines from ACR and KDIGO have evolved to shape lupus nephritis treatment approaches, emphasizing their critical role in standardizing patient care and incorporating recent advances like new therapeutic options and refined diagnostic criteria.
EP: 1.Understanding the Clinical Burden and Prevalence of Lupus Nephritis
EP: 2.Cost Drivers in Lupus Nephritis
EP: 3.Urgency to Treat in Lupus Nephritis: Goals of Therapy and Early Diagnosis Strategies
EP: 4.Guideline Updates in Lupus Nephritis: Impacts on Clinical Decision-Making
EP: 5.Tailoring Lupus Nephritis Treatment: Key Considerations and Specialist Approaches
EP: 6.Belimumab and Voclosporin: Clinical Insights and Payer Evaluations in Lupus Nephritis
EP: 7.Improving Access to Lupus Nephritis Treatment: Strategies and Resources
EP: 8.Lupus Nephritis Management: Monitoring Strategies and Long-Term Study Results
EP: 9.Collaborating for Better Care: Healthcare Providers and Payers in Lupus Nephritis
EP: 10.From Guidelines to Practice: Advancing Lupus Nephritis Treatment
EP: 11.Looking Ahead: Anticipating Changes in Lupus Guidelines and Clinical Practice
Video content above is prompted by the following:
- In your view, why are guidelines for lupus nephritis important to patient care?
- What role do the American College of Rheumatology (ACR) and Kidney Disease Improving Global Outcomes (KDIGO) guidelines play in shaping treatment practices for lupus nephritis?
- What are some of the most significant recent changes in lupus nephritis guidelines?
- How has the treatment approach for lupus nephritis evolved in recent years alongside these guidelines?
Immune Checkpoint Inhibitors More Effective vs Bevacizumab in Nonsquamous NSCLC
August 6th 2025Bevacizumab combined with chemotherapy was not as effective in advanced driver gene-negative nonsquamous non–small cell lung cancer (NSCLC) compared with immune checkpoint inhibitors plus chemotherapy.
Read More
Higher Oxidative Balance Score Linked to Lower Systemic Inflammation, Study Finds
August 5th 2025Researchers discovered a significant negative correlation between an individual's oxidative balance score and systemic immune-inflammation index, highlighting the role of antioxidants in reducing inflammation.
Read More
Bridging the Gaps: New Strategies for Preventing Cardiovascular Disease
July 31st 2025During the Addressing Cardiovascular Risk and Intervening Early webinar, experts discussed innovative strategies for cardiovascular disease prevention, emphasizing risk assessment, lifestyle changes, and collaborative care to improve patient outcomes.
Read More
